How the Celesio Deal Benefits McKesson

How the Celesio Deal Benefits McKesson Play

Jan. 24 (Bloomberg) -- McKesson, the largest U.S. drug distributor, said it will acquire Celesio AG just 10 days after a failed tender offer for the rival European company. David Tweed reports on Bloomberg Television's "Countdown." (Source: Bloomberg)

  • On Air Now

    Conversation w Lloyd Blankfein & Michael Bloomberg Watch Now

  • Next

    SHOOTOUT: Can Nike Beat Adidas at Soccer?

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus